Halozyme Therapeutics, Inc. · San Diego, CA United States · (NASDAQ (GM): HALO)
Company Description
More Companies in: San Diego, California
More Companies in These Related Industries: Pharmaceutical Preparation Mfg, Biologics Mfg
View Halozyme Therapeutics, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Halozyme Therapeutics makes enzymes for therapeutic and drug delivery applications. The company's products are based on recombinant human PH20, a human synthetic enzyme it hopes will offer safety benefits over animal-derived versions. The firm's first commercial product, Cumulase, is used for in-vitro fertilization. Another product, Hylenex, is used as an adjuvant for drug and fluid infusions. Products under development include drug delivery agents using the company's Enhanze technology, as well as therapeutic enzymes for cancer, metabolism, and dermatology applications. Halozyme's development partners include
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Halozyme Therapeutics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports for this company now.
Download presentation-ready reports for this company now.
From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.
Key Halozyme Therapeutics, Inc. Financials
| Company Type | Public - NASDAQ (GM): HALO Headquarters |
| Fiscal Year-End | December |
| 2009 Employees | 139 |
Halozyme Therapeutics, Inc. Executives
30 executives listed for Halozyme Therapeutics, Inc.'s San Diego, CA location.
| Title | Name & Bio | Contact |
| Chairman | Kenneth Kelley | |
| President, CEO, and Director | Jonathan Lim | |
| VP Manufacturing and Operations | William Fallon |
Competition
Competitive Landscape for Halozyme Therapeutics, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Halozyme Therapeutics, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!